Cotización Pluri - PLUR

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

4.90

Postura de Compra

4.65

Postura de Venta

5.19

Volume Operado de la Acción

2,590

4.72 Rango del Día 4.90

3.7728 Rango de 52 semanas 8.48

Capitalización de Mercado [m]

27.237M

Precio Anterior

4.70

Precio de Apertura

4.80

Hora

4.65

Última hora de negociación

Volumen financiero

US$ 12,574

Precio Promedio Ponderado

4.8549

Volumen promedio (3 m)

21,416

Acciones en circulación

5,558,662

Rendimiento del Dividendo

Ratio Precio/Utilidad

-1.30

Beneficio por acción (BPA)

-3.76

turnover

326k

Beneficio neto

-20.89M

Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. Th... Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pluristem Therapeutics Inc. Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. Mostrar más

Sector

Biological Pds,ex Diagnstics

Industria

Biological Pds,ex Diagnstics

Sitio web

www.pluristem.com

Sede

Haifa, North, Isr

Fundado

Pluri Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PLUR. The last closing price for Pluri was US$4.70. Over the last year, Pluri shares have traded in a share price range of US$ 3.7728 to US$ 8.48.

Pluri currently has 5,558,662 shares in issue. The market capitalisation of Pluri is US$26.13 million. Pluri has a price to earnings ratio (PE ratio) of -1.30.

Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority

The Israel Innovation Authority will fund Pluri and BIRAD's collaboration to advance MAIT Cell Therapy, led by Professor Cyrille Cohen, Head of the laboratory of tumor immunology and immunotherapy...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.79	-13.8840070299	5.69	5.69	4.57	9433	4.99677289	CS
4	0.58	13.4259259259	4.32	6.14	4.29	34648	5.12577333	CS
12	-0.76	-13.4275618375	5.66	6.18	4.24	21416	5.16362705	CS
26	-1.17	-19.2751235585	6.07	6.72	4.24	13109	5.27017226	CS
52	0.4248	9.49231319271	4.4752	8.48	3.7728	49859	5.74122327	CS
156	-3.1	-38.75	8	11.5784	3.4488	58773	6.41322286	CS
260	-3.1	-38.75	8	11.5784	3.4488	58773	6.41322286	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	897.51k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	22.89M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	305.85k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	3.93M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	107.91M